OX40 (CD134) engagement drives differentiationof CD4+ T cells to effector cells
Authors:
Open Access
- 25 April 2006
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 36 (5) , 1093-1103
Abstract
Naive, CD4+ T cells proliferate extensively but fail to differentiate when they are transferred into unirradiated recipients that express alloantigen or transgenic antigen on all MHC class II+ cells. Addition of an agonist antibody to OX40 (CD134), a costimulatory TNF receptor family member expressed on activated CD4+ T cells, enables the proliferating T cells to accumulate as differentiated effector cells and kill the host animals. The donor T cells from anti‐OX40‐treated animals express high levels of IL‐2Rα (CD25) and acquire the ability to secrete IFN‐γ when stimulated with IL‐12 and IL‐18. OX40 promotes differentiation by 48 h in T cell priming, before changes in Bcl‐2 expression or cell recovery become apparent. We found that a Bcl‐2 transgene or deficiency in Fas or TNFR1 failed to influence accumulation of differentiated donor cells, and found larger changes in expression of cytokine and cytokine receptor genes than in survival genes. Accumulation of differentiated CD4+ effector T cells is initiated directly through OX40, but some OX40‐deficient donor cells can gain effector function as bystanders to OX40+/+ cells. Taken together, these data suggest that CD4+ T cell differentiation to effector function is an important effect of OX40 engagement under conditions of ubiquitous antigen presentation.Keywords
This publication has 48 references indexed in Scilit:
- Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNAInternational Immunology, 2005
- Sustained Survivin Expression from OX40 Costimulatory Signals Drives T Cell Clonal ExpansionImmunity, 2005
- TNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSESAnnual Review of Immunology, 2005
- Donor-derived IL-15 is critical for acute allogeneic graft-versus-host diseaseBlood, 2005
- Interleukin 7 Regulates the Survival and Generation of Memory CD4 CellsJournal of Experimental Medicine, 2003
- Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipientsBlood, 2003
- Tolerogenic Dendritic CellsAnnual Review of Immunology, 2003
- RETRACTED: The Fas/Fas Ligand Pathway and Bcl-2 Regulate T Cell Responses to Model Self and Foreign AntigensImmunity, 1998
- Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor.Journal of Experimental Medicine, 1994
- Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivoImmunity, 1994